# UNITED THERAPEUTICS Corp: filings

UTHR · Nasdaq · CIK 1082554 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uthr.md) · [Financials](/companies/uthr/financials.md) · [Filings](/companies/uthr/filings.md) · [Insiders](/companies/uthr/insiders.md)

## Reports and events: 324 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 2474, 144 250, 8-K 229, SC 13G/A 83, 10-Q 53, 4/A 40, SC 13G 22, UPLOAD 21, DEF 14A 19, 10-K 18, DEFA14A 18, S-8 17, 3 15, CORRESP 15, CT ORDER 14, SD 13, S-8 POS 10, ARS 9, SCHEDULE 13G/A 5, 8-K/A 3, PRE 14A 3, SC TO-C 3, SC TO-T/A 3, SC 13D 2, SCHEDULE 13G 2, 8-A12G/A 1, EFFECT 1, NO ACT 1, S-4 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 07:00 ET | [8-K](/filings/0001104659-26-117964.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117964 |
| 2026-10-14 | 07:00 ET | [8-K](/filings/0001104659-26-115723.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115723 |
| 2026-09-08 | 17:12 ET | [8-K](/filings/0001104659-26-105953.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105953 |
| 2026-08-05 | 06:33 ET | [8-K](/filings/0001082554-26-000028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000028 |
| 2026-08-05 | 06:31 ET | [10-Q](/filings/0001082554-26-000027.md) | Quarterly report, period 2026-06-30 | 0001082554-26-000027 |
| 2026-07-23 | 07:00 ET | [8-K](/filings/0001104659-26-086068.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-086068 |
| 2026-06-29 | 16:32 ET | [8-K](/filings/0001104659-26-078865.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-078865 |
| 2026-05-06 | 06:31 ET | [8-K](/filings/0001082554-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000021 |
| 2026-05-06 | 06:30 ET | [10-Q](/filings/0001082554-26-000020.md) | Quarterly report, period 2026-03-31 | 0001082554-26-000020 |
| 2026-04-29 | 06:33 ET | [DEF 14A](/filings/0001082554-26-000009.md) | Proxy statement, period 2026-06-26 | 0001082554-26-000009 |
| 2026-03-30 | 07:00 ET | [8-K](/filings/0001104659-26-036445.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-036445 |
| 2026-03-09 | 17:18 ET | [8-K](/filings/0001104659-26-025331.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-025331 |
| 2026-03-02 | 06:32 ET | [8-K](/filings/0001104659-26-021869.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-021869 |
| 2026-02-25 | 06:32 ET | [8-K](/filings/0001082554-26-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-26-000007 |
| 2026-02-25 | 06:31 ET | [10-K](/filings/0001082554-26-000006.md) | Annual report, period 2025-12-31 | 0001082554-26-000006 |
| 2026-01-22 | 16:31 ET | [8-K](/filings/0001104659-26-005810.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-005810 |
| 2025-10-29 | 06:34 ET | [8-K](/filings/0001082554-25-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000036 |
| 2025-10-29 | 06:32 ET | [10-Q](/filings/0001082554-25-000034.md) | Quarterly report, period 2025-09-30 | 0001082554-25-000034 |
| 2025-09-02 | 07:00 ET | [8-K](/filings/0001104659-25-085976.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-085976 |
| 2025-08-01 | 17:17 ET | [8-K](/filings/0001104659-25-073163.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-073163 |
| 2025-07-30 | 06:36 ET | [8-K](/filings/0001628280-25-036543.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036543 |
| 2025-07-30 | 06:34 ET | [10-Q](/filings/0001628280-25-036541.md) | Quarterly report, period 2025-06-30 | 0001628280-25-036541 |
| 2025-06-27 | 07:30 ET | [8-K](/filings/0001104659-25-063287.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-063287 |
| 2025-04-30 | 06:33 ET | [8-K](/filings/0001082554-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000024 |
| 2025-04-30 | 06:32 ET | [10-Q](/filings/0001082554-25-000023.md) | Quarterly report, period 2025-03-31 | 0001082554-25-000023 |
| 2025-04-29 | 06:31 ET | [DEF 14A](/filings/0001082554-25-000014.md) | Proxy statement, period 2025-06-26 | 0001082554-25-000014 |
| 2025-04-28 | 06:31 ET | [8-K](/filings/0001104659-25-039710.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-039710 |
| 2025-02-26 | 06:35 ET | [8-K](/filings/0001082554-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-25-000007 |
| 2025-02-26 | 06:33 ET | [10-K](/filings/0001082554-25-000005.md) | Annual report, period 2024-12-31 | 0001082554-25-000005 |
| 2025-01-13 | 08:57 ET | [8-K](/filings/0001104659-25-002892.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002892 |
| 2024-10-30 | 06:34 ET | [8-K](/filings/0001082554-24-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000049 |
| 2024-10-30 | 06:32 ET | [10-Q](/filings/0001082554-24-000047.md) | Quarterly report, period 2024-09-30 | 0001082554-24-000047 |
| 2024-07-31 | 06:33 ET | [8-K](/filings/0001082554-24-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000037 |
| 2024-07-31 | 06:31 ET | [10-Q](/filings/0001082554-24-000035.md) | Quarterly report, period 2024-06-30 | 0001082554-24-000035 |
| 2024-06-27 | 07:30 ET | [8-K](/filings/0001104659-24-075375.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-075375 |
| 2024-05-01 | 06:34 ET | [8-K](/filings/0001082554-24-000027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-24-000027 |
| 2024-05-01 | 06:32 ET | [10-Q](/filings/0001082554-24-000025.md) | Quarterly report, period 2024-03-31 | 0001082554-24-000025 |
| 2024-04-29 | 07:00 ET | [DEF 14A](/filings/0001082554-24-000017.md) | Proxy statement, period 2024-06-26 | 0001082554-24-000017 |
| 2024-03-29 | 16:30 ET | [8-K](/filings/0001104659-24-041160.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001104659-24-041160 |
| 2024-03-25 | 16:56 ET | [8-K](/filings/0001104659-24-038478.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-038478 |
| 2024-02-27 | 06:03 ET | [8-K](/filings/0001104659-24-027791.md) | 8.01 Other events | 0001104659-24-027791 |
| 2024-02-21 | 06:05 ET | [8-K](/filings/0001082554-24-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001082554-24-000007 |
| 2024-02-21 | 06:03 ET | [10-K](/filings/0001082554-24-000005.md) | Annual report, period 2023-12-31 | 0001082554-24-000005 |
| 2023-12-22 | 09:51 ET | [SC 13D](/filings/0001104659-23-128620.md) | Ownership report, active investor | 0001104659-23-128620 |
| 2023-12-20 | 17:00 ET | [8-K](/filings/0001104659-23-127766.md) | 8.01 Other events | 0001104659-23-127766 |
| 2023-11-29 | 06:00 ET | [8-K](/filings/0001104659-23-121738.md) | 8.01 Other events | 0001104659-23-121738 |
| 2023-11-01 | 06:05 ET | [8-K](/filings/0001082554-23-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-23-000033 |
| 2023-11-01 | 06:03 ET | [10-Q](/filings/0001082554-23-000031.md) | Quarterly report, period 2023-09-30 | 0001082554-23-000031 |
| 2023-08-02 | 06:05 ET | [8-K](/filings/0001082554-23-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001082554-23-000024 |
| 2023-08-02 | 06:02 ET | [10-Q](/filings/0001082554-23-000022.md) | Quarterly report, period 2023-06-30 | 0001082554-23-000022 |

Page 1 of 7. [Older](/companies/uthr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:40 ET. No prices; not investment advice.